Biopharma
+51
Biopharmaceutical Company (2025 Update)
This group pushes boundaries in targeted therapeutics, from redirecting immune responses within the tumor microenvironment to pioneering novel approaches for neurodegenerative diseases and autoimmune disorders. Innovation spans a diverse range of modal...
👋🏼 Hi, I'm Bounce Watch. Let's explore what's happening in Biopharmaceutical Company!
Real-Time Scouting Assistant
Explore Biopharmaceutical Company featuring 58 Companies in Biopharma Industry
|
|
|
|||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
Urovant Sciences | - | is part of Sumitomo Pharma America as of July 2023 | This page is no longer active or monitored. We are now Sumitomo Pharma America (... | - |
United States
|
Irvine | United States (HQ) + 1 | 2017 | Biopharma, Biotechnology +1 | [email protected] |
1
Low
|
97
|
285 | 6 years ago | Debt Financing | 1 | 100.0M | 11957 | 1 year ago | |
|
|
|
Wren Therapeutics | - | Stopping the wave of neurodegeneration at its source | WaveBreak (www.WaveBreakTx.com) is a biopharmaceutical company focused transform... | - |
United Kingdom
|
Cambridge | United Kingdom (HQ) | 2016 | Biopharma, Biotechnology +2 | [email protected] |
1
Low
|
34
|
569 (-100%) | 4 years ago | Series Unknown | 3 | 30.4M | 2143 | 1 year ago | |
|
|
|
Mereo BioPharma | - | Mereo BioPharma is a clinical-stage company focused on developing & commercialis... | Welcome to Mereo BioPharma, we are an agile biopharmaceutical company, focused o... | - |
United Kingdom
|
London | United Kingdom (HQ) + 1 | 2015 | Biopharma, Biotechnology +1 | - |
1
Low
|
45
|
3.1K (-21%) | 11 months ago | Post Ipo Equity | 6 | 387.5M | 4621 | 5 months ago | |
|
|
|
ENYO Pharma | - | Developing therapeutics for diseases with impaired kidney function | ENYO Pharma is developing innovative therapeutics based on fibrolytic and anti-i... | - |
France
|
- | France (HQ) | 2014 | Biopharma, Biotechnology | [email protected] |
1
Low
|
33
|
1.3K (64%) | 1 year ago | Series C | 4 | 103.5M | 7622 | 5 months ago | |
|
|
|
Enterome | - | Delivering the promise of immunotherapy | Enterome is a clinical-stage biopharmaceutical company developing breakthrough i... | - |
France
|
- | France (HQ) + 1 | 2011 | Biopharma, Biotechnology +2 | [email protected] |
1
Low
|
66
|
1.8K (-33%) | 1 year ago | Series Unknown | 3 | 175.8M | 15123 | 5 months ago | |
|
|
|
Silverback Therapeutics | - | - | We are a clinical-stage biopharmaceutical company leveraging our proprietary Imm... | - | - | - | - | 2016 | Biopharma, Biotechnology +2 | [email protected] |
1
Low
|
7
|
800 | 4 years ago | Series C | 5 | 221.0M | 8125 | 1 N93 AqJ | |
|
|
|
Dermira, Inc. | - | - | Dermira is a biopharmaceutical company dedicated to bringing biotech ingenuity t... | - |
United States
|
Menlo Park | United States (HQ) | 2010 | Biopharma, Biotechnology +1 | [email protected] |
1
Low
|
24
|
331 | 6 years ago | Post Ipo Equity | 13 | 1.1B | 10022 | 6 Xn9 kJu | |
|
|
|
Naurex Inc. | Not active anymore | - | Naurex is a biopharmaceutical company developing novel modulators of the NMDA re... | - | - | - | - | 2008 | Biopharma, Biotechnology +1 | [email protected] |
-1
N/A
|
9
|
201 | 10 years ago | Series C | 5 | 200.1M | 21002 | 9 rU4 0k9 | |
|
|
|
Affymax | - | Pioneering innovative therapies for life-threatening conditions, aiming to enhan... | Affymax is a biopharmaceutical company dedicated to creating innovative drugs th... | - | - | - | - | 2001 | Biopharma, Biotechnology +1 | [email protected] |
1
Low
|
236
|
311 | 16 years ago | Series Unknown | 4 | 173.0M | 23 | 5 3hO AwJ | |
|
|
|
Genelabs Technologies | - | - | Genelabs is a biopharmaceutical company focused on the discovery and development... | - | - | - | - | 1983 | Biopharma, Biotechnology +2 | - |
1
Low
|
24
|
1.2K (175%) | 17 years ago | Series Unknown | 2 | 17.3M | 31183 | 1 OwY 4Tz |